论文部分内容阅读
反跳是慢性肝炎患者联苯双酯治疗后的突出问题．当前应用本药治疗后的停药方式，大多以ＡＬＴ作为指标．于ＡＬＴ正常一段时间后，停药或开始减少联苯双酯用量停用．作者用一次性停药，与分次减药至停药进行对比，并对ＡＬＴ，ＡＳＴ检测水平与反跳率的关系进行观察．１ 材料
Bounce is a prominent issue after bifendate treatment in patients with chronic hepatitis. The current application of drug withdrawal after treatment, mostly with ALT as an indicator. After ALT for a period of time, withdrawal or start to reduce the dosage of bifendate disabled. The authors used a one-time withdrawal, compared with the reduction of drug to withdrawal, and observed the relationship between ALT, AST levels and rebound rate. 1 material